Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.3, replacing the previous v3.5.2, indicating a backend build update with no changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T17:39:50.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:27:43.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:47:04.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    - The site revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:16:08.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added results metrics (pathologic complete response rate, overall survival, disease-free survival) and counts of drug-related toxicities with posting dates; included investigator/site details (Arsen Osipov, MD; Cedars-Sinai; The University of Texas Health Science Center at San Antonio) and attached the Study Protocol and Statistical Analysis Plan document.
    Difference
    3%
    Check dated 2026-02-11T01:46:11.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A government funding lapse notice about data currency and NIH operations was added, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:43:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.